4,0
27 mar 2024
Dipendente attuale, più di un anno
Sydney
Consiglia
Gradimento del CEO
Pronostico commerciale
Vantaggi
Since exiting DXC Dedalus is demonstration real progress and intent to increase its investment and footprint across healthcare. One to watch.
Svantaggi
As with most transformations post exiting a large parent organisation there remains improvement across processes and identity. This will come in time with focus.